Mayo Clinic News Network

News Resources

Items tagged as "individualized medicine"

National DNA Day is April 25; Experts Available for Comment

ROCHESTER, Minn. — Friday, April 25, is National DNA Day, the date which commemorates completion of the Human Genome Project, the national effort to identify and decode all 6 billion letters in human DNA. Since that time, medical researchers and practitioners have found new ways to apply genomics for everyone who [...]

Created by Sam Smith

Mayo Clinic Shares Lessons Learned from Genomics Clinic for Sequencing-based Cancer Care and Diagnostics

ROCHESTER, Minn. — It has been 1.5 years since Mayo Clinic opened the world’s first integrated multidisciplinary genomics service, the Individualized Medicine Clinic, which uses genomics and next-generation sequencing technologies to personalize treatments for patients with advanced cancer and complex diagnoses. In a special issue of the American Journal of [...]

Created by Sam Smith

Implications of Patient Genomic Sequencing at ACMG

ROCHESTER, Minn. — Researchers from the Mayo Clinic Center for Individualized Medicine will present results of three different studies evaluating implications and feasibility of genome sequencing at the ACMG Annual Clinical Genetics Meeting this week in Nashville, Tenn. Presenters are available for interviews at the conference or remote interviews by [...]

Created by Sam Smith

Mayo Clinic Develops Faster Tumor Analysis Software, Speeds Cancer Discoveries

ROCHESTER, Minn. — Feb. 24, 2014 — Mayo Clinic researchers have fashioned a new key to unlocking the secrets of the human genome. The Binary Indexing Mapping Algorithm, version 3 (BIMA V3) is a freely available computer algorithm that identifies alterations in tumor genomes up to 20 times faster and [...]

Created by Sam Smith

Researchers Use Genomic Sequencing to Help Identify New Therapies for Bile Duct Cancer

Study targets EGFR and FGFR cellular pathways to treat rare disease SCOTTSDALE, Ariz. — Feb. 13, 2014 — Physicians at Mayo Clinic’s Center for Individualized Medicine and researchers at the Translational Genomics Research Institute (TGen) have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing technologies. Potential new treatment approaches are being [...]

Created by Sam Smith

Científicos de Mayo Clinic proponen usar fármaco para cáncer de mama en pacientes con cáncer vesical

ROCHESTER, Minnesota — 21 de enero de 2014 — Los científicos de Mayo Clinic descubrieron una amplificación de HER2, conocida por conducir a algunos cánceres de mama, en un tipo de cáncer de vejiga llamado carcinoma urotelial micropapilar (MPUC, por sus siglas en inglés), y demostraron que la presencia de [...]

Created by Soledad Andrade

Edición electrónica de Discovery’s Edge

Rochester, Minnesota — 8 de enero de 2014 — A continuación se presenta la última edición electrónica de Discovery's Edge, la revista sobre las investigaciones de Mayo Clinic. Usted puede citar y enlazar esta publicación con la frecuencia que desee, pero la reproducción se permite solamente con la debida atribución; [...]

Created by Soledad Andrade

Mayo Clinic Scientists Propose a Breast Cancer Drug for Bladder Cancer Patients

ROCHESTER, Minn. ― Jan. 21, 2014 ― Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. [...]

Created by Sam Smith

Discovery’s Edge Online Issue

Research Features from Mayo Clinic Rochester, Minn. — January  8, 2014 — Here are highlights from the latest online issue of Discovery's Edge, Mayo Clinic's research magazine. You may cite and link to this publication as often as you wish. Republication is allowed with proper attribution. Please include the following subscription information [...]

Created by Bob Nellis

Sisters Have Same Breast Cancer Risk But Made Different Decisions (pkg)

The risk most women have of getting breast cancer in their lifetime is 12 percent. But if a woman tests positive for one of two known breast cancer genes, that risk shoots up to as high as 80 percent. The sisters in this story both tested positive for a [...]

Created by Dana Sparks


If you could peer into the future of medical care, individualized medicine would be what you see.  On Saturday, Oct. 5, we will broadcast from the Individualizing Medicine Conference, in Rochester, Minn.  We’ll discuss how the promise of genomic medicine has been brought into the medical practice and what genomics advances mean [...]

Created by Dana Sparks

Flu Vaccines - Changes & Choices for 2013

Allergic to eggs? There’s now an influenza vaccination just for you. Fearful of needles? It won’t stop you from getting the flu vaccine. The next flu shot season will bring several new vaccine options for consumers, and Mayo Clinic vaccine expert Gregory Poland, M.D., says patients need not feel bewildered. The new choices move [...]

Created by Dennis Douda

#FutureOfHealthCare on CNBC Closing Bell

  What is the #FutureOfHealthCare? Mayo Clinic President and CEO John Noseworthy, M.D., speaks with @MariaBartiromo on @CNBCClosingBell about the Affordable Care Act, Destination Medical Center (DMC), individualized medicine, regenerative medicine, health care delivery, NIH funding and more ... WATCH VIDEO: 

Created by Dana Sparks

First Whole Exome Sequence of Small-Intestine Carcinoids

Researchers at Mayo Clinic have completed the world’s first whole exome sequence of small intestine neuroendocrine tumors, also known to patients and physicians as carcinoids, the most common cancer of the small bowel and one that responds poorly to chemotherapy. Mayo oncologist and lead author Michaela Banck, M.D., says, “This is [...]

Created by Dana Sparks

27 Genes Make Rubella Vaccine Less Effective

Using advanced genetic sequencing technology and analysis, Mayo Clinic vaccine researchers have identified 27 genes that respond in very different ways to the standard rubella vaccine, making the vaccine  less effective for a portion of the population. Mayo Clinic vaccinologist Gregory Poland, M.D., says, “This study highlighted the genes potentially responsible [...]

Created by Dana Sparks

Register for 2013 Individualizing Medicine Conference

Registration is open for Individualizing Medicine 2013: From Promise to Practice. This year the conference focuses on how to implement genomics technologies in clinical care. September 29—October 2, and CME is available at many conference sessions. Eric Green, M.D., Ph.D., head of the NIH’s National Human Genome Research Institute, will [...]

Created by Dana Sparks

The Genome Project - Determining All 6 Billion Letters of Human DNA

This week marks the 10th anniversary of the completion of the Human Genome Project, a roughly 10-year, $3-billion, international effort to determine all 6 billion letters (3 billion base pairs) of human DNA. It was a major scientific achievement funded by the National Institutes of Health, Department of Energy, several [...]

Created by Dana Sparks

Strategic Relationship on Genome Diagnostics

Mayo Clinic and Silicon Valley Biosystems (SV Bio) are announcing a strategic collaboration for whole genome diagnostics and interpretation at the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories. This strategic collaboration unites SV Bio’s proprietary genome interpretation solution with Mayo Clinic’s growing genome reference library and its commitment [...]

Created by Dana Sparks

Individualized Medicine 2012 Conference

The conference has concluded. Thank you to all who participated. The sessions will be archived and made available on the News Network Monday Oct. 8th.  Schedule: Conference Agenda  Blog: Advancing the Science  Follow Twitter #MayoCIM  Conference sessions will be archived  Journalists can email  

Created by Dana Sparks